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Growth factors promote cell survival and cell motility, Results and discussion
To examine which molecules are involved in cell motility,presumably through the activation of Akt and the
Rac and Cdc42 GTPases, respectively [1, 2]. Because we employed the “modified” Boyden chamber assay,
which enables us to count GFP-labeled cells migratingAkt is dispensable for Rac/Cdc42 regulation of
actin reorganization, it has been assumed that Rac across a fluorescence-blocking planar micropore mem-
brane in real time [7, 8]. In this assay, PDGF-stimulatedand Cdc42 stimulate cell motility independent of
Akt in mammalian cells [3–5]. However, in this study cell motility was suppressed by expression of a dominant-
negative Rac (RacN17) but not dominant-negative Cdc42we demonstrate that Akt is essential for Rac/
Cdc42-regulated cell motility in mammalian (Cdc42 N17) nor Rho (Rho N19) (Figure 1a,b), consistent
with previous reports [9, 10]. Importantly, we found thatfibroblasts. A dominant-negative Akt inhibits cell
motility stimulated by Rac/Cdc42 or by PDGF expression of a dominant-negative mutant (K197A/T308A/
S473A) of Akt resulted in marked reduction of PDGF-treatment, without affecting ruffling membrane-
type actin reorganization. We have confirmed a stimulated cell motility (Figure 1a,b). Under the same
conditions, expression of the dominant-negative Akt didprevious report that Akt is activated by expression
of Rac and Cdc42 [6] and also observed not affect membrane ruffling induced by PDGF (data not
shown), as previously described in other systems [3, 4].colocalization of endogenous phosphorylated Akt
with Rac and Cdc42 at the leading edge of Therefore, Akt is necessary for PDGF-stimulated cell
motility without affecting membrane ruffling. This is con-fibroblasts. Importantly, expression of active Akt
but not the closely related kinase SGK is sufficient sistent with a previous report showing that Schwann cells
expressing K197M-Akt were resistant to IGF-I stimula-for increasing cell motility. This effect of Akt is cell
autonomous and not mediated by inhibition of tion of cell motility [11].
GSK3. Finally, we found that dominant-negative
Akt but not SGK reverses the increased cell motility Because both Rac and Akt are necessary for PDGF-
phenotype of fibroblasts lacking the PTEN tumor induced cell motility, it is possible that these molecules
suppressor gene. Taken together, these results interact functionally. Previous reports have shown that
suggest that Akt promotes cell motility Rac andCdc42 can be an upstream activator of Akt inmast
downstream of Rac/Cdc42 in growth factor- cells and T lymphocytes [6]. We found that expression of
stimulated cells and in invasive PTEN-deficient active Rac (Rac V12) or Cdc42 (Cdc42 V12) similarly
cells. induced phosphorylation of Akt in NIH3T3 and COS-1
cells, on both T308 and S473, the phosphorylation sites
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homology) domain (GFP-PHAkt) was expressed in these
cells, it was also localized at the leading edge of polarized
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Figure 1 fibroblasts (Figure 2d), consistent with the recent finding
that GFP-PHAkt is localized at the lamelipodia of neutro-
phils [13]. Therefore, in fibroblasts, active Akt appears to
localize at the leading edge with Rac and Cdc42.
Because both Rac and Akt are necessary for PDGF-stimu-
lated cell motility (Figure 1) and because Rac and Cdc42
induce phosphorylation of Akt (Figure 2), we next asked
whether Akt is required for Rac- and Cdc42-stimulated
cell motility. Expression of Rac V12 or Cdc42 V12 stimu-
lated cell motility (Figures 2d, and 3a,b) [14]. Coexpres-
sion of dominant-negative Akt suppressed cell motility
stimulated by active Rac and Cdc42 to the basal levels
(Figure 2d), suggesting that Akt is an essential down-
stream effector of Rac and Cdc42 in stimulating cell mo-
tility.
Since Akt appears to be required for PDGF- and Rac/
Cdc42-stimulated cell motility, we then asked whether
Akt is sufficient for stimulation of cellmotility. Expression
of an active form of Akt promoted cell motility to a greater
degree than expression of active Rac (Figure 3ab). This
effect of Akt was cell autonomous (Figure 3c). In contrast,
expression of active Akt had little effect on membrane
ruffling and reorganization of the underlying actin cy-
toskeleton (data not shown) [3–5]. Therefore, Rac/Cdc42
may utilize two separate pathways to promote cell motil-
ity; one is an Akt-dependent pathway, and the other is a
pathway leading to actin reorganization (Supplementary
Figure S7). This model is further supported by the result
that dominant-negative Rac inhibited Akt-stimulated cell
motility only partially (see Supplementary material).
PI3-K and its downstream effector PDK1 activate a num-
ber of molecules in addition to Akt, including SGK. SGK
is activated by PDK1-mediated phosphorylation and has
substrate specificity very similar to Akt [15]. It is therefore
possible that SGK also mediates PI3-K-stimulated cell
motility. However, expression of an active SGK did not
affect cell motility (Figure 3a,b). Moreover, dominant-
negative SGKdid not inhibit PDGF- orRac/Cdc42-stimu-
lated cell motility (Figures 1ab and 2d). These results
suggest that Akt but not SGK promotes cell motility
downstream of the PI3-K-PDK1 pathway.
Dictyostelium Akt (DdPKB) is necessary for establishing
cell polarity and for chemotaxis, through the direct phos-
Inhibition of Akt prevents PDGF-stimulated cell motility of Rat1 phorylation of DdPAK [16, 17]. This mechanism does not
fibroblasts. Cells were cotransfected with a GFP-expressing vector appear to be conserved between the species, because the
(pEGFP) and either control vector (pcDNA3), Rac N17, Cdc42 N17,
Akt phosphorylation site on DdPAK is not conserved inRho N19, Akt DN (K197A, T308A, S473A), or SGK DN (T256A,
S422A) for 20 hr. (a,b) Cells were transferred to the upper
compartment of the modified Boyden chamber [7] in the presence
() or absence () of 20 ng/ml PDGF. After 2 hr, the GFP-positive
for 18 hr. After 30 min of PDGF treatment, each set of NIH3T3 cellscells that had migrated through the membrane were counted. Typical
was harvested and subjected to immunoblotting with anti-phosphoimages of migrated cells are shown in (a). Results are presented as
Akt(Ser473) or anti-Akt antibody.mean  SD of at least four independent experiments in (b). (c)
Wild-type Akt was cotransfected with each of the indicated constructs
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Figure 2 mammalian PAKs and also because the localization of
DdPAK at the posterior end of a moving cell is distinctly
opposite of the localization of mammalian PAKs at the
leading edge [16]. In addition, overexpression of DdPKB
reduces cell motility [17]. In contrast, our results demon-
strate that overexpression of mammalian Akt promotes
cell motility. Given these results, how does Akt promote
cell motility? It has recently been shown that inhibition
of GSK3 downstream of PI3-K induces CLASP redistribu-
tion to the distal ends of microtubules, which stabilizes
themicrotubules andmay contribute to the establishment
of cell polarity [18]. Since Akt is known to inhibit GSK3
[19], we examined whether inhibition of GSK3 can mimic
the effect of Akt. Expression of a dominant-negative
GSK3 (GSK3 DN) did not promote cell motility (Figure
3b). Also, coexpression of wild-type GSK3 (GSK3 WT)
did not block the stimulating effect of Akt on cell motility
(Figure 3d). Therefore, it is unlikely that GSK3 serves
as the primary target for Akt in regulating cell motility.
PTEN (phosphatase and tensin homolog deleted on chro-
mosome 10) is a tumor suppressor gene which is deleted
or mutated in a variety of primary human cancers [20].
PTEN dephosphorylates PI(3,4,5)P3, a product of PI3-K,
and antagonizes the effects of PI3-K on apoptosis and cell
migration [21]. Recently, it has been shown that PTEN
negatively controls cell motility by downregulating Rac
andCdc42 [22]. Since our data suggest that Akt acts down-
stream of Rac and Cdc42 in the regulation of cell motility,
we examined whether Akt mediates the upregulation of
cell motility in the PTEN-deficient cells. We confirmed
that phosphorylation of Akt is elevated in the PTEN-
deficient mouse embryonic fibroblasts (PTEN/ MEFs)
compared to the level in PTEN/MEFs (Figure 4b) and
that the cell motility of the PTEN-deficient MEFs is
higher than that of PTEN/ MEFs (Figure 4a). When a
dominant-negative Akt was introduced into the PTEN-
deficient MEFs, the motility was markedly reduced (Fig-
ure 4a), whereas a dominant-negative SGK had no effect
(Figure 4a). Therefore, the elevated activity of Akt in the
PTEN-deficientMEFs is essential for their increased cell
motility.
In conclusion, we have shown that mammalian Akt plays
an essential role in promoting cell motility in growth fac-
tor-stimulated cells and in PTEN-deficient cells (Supple-
mentary Figure S7). Since Akt itself is an oncogene and
may be activated in many types of cancers, it would be
(a) Rac and Cdc42 induce phosphorylation of Akt. NIH3T3 cells were
transfected with each of the indicated constructs, together with
PHAkt for 20 hr. Cells were replated on a poly-D-lysine-coated glass-wild-type Akt (Akt WT) for 18 hr. Cell lysates were subjected to
bottomed dish and cultured for 6 hr, then GFP fluorescence wasimmunoblotting with anti-phospho Akt (Ser473 or Thr308) or anti-
detected. (d) Inhibition of Akt prevents Rac/Cdc42-stimulated cellAkt antibody. (b) Phosphorylated Akt colocalizes with Rac/Cdc42 at
motility of Rat1 fibroblasts. Cells were transfected with the indicatedthe leading edge of polarized fibroblasts. NIH3T3 cells were plated
constructs for 20 hr. Migration was quantified 2 hr after transfer toon coverslips and cultured for 20 hr. After fixation in 10% trichloroacetic
the Boyden chamber.acid on ice, cells were stained with antibodies against phospho-Akt
(Ser473) or Rac/Cdc42. (c) NIH3T3 cells were transfected with GFP-
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Figure 3
Expression of active Akt increases motility of
Rat1 fibroblasts. Cells were transfected with
each of the indicated constructs, together with
pEGFP, for 20 hr. The migrated cells were
detected 2 hr after transfer to the Boyden
chamber. (a) Typical images of migrated
cells. (b–d) Results are presented as mean 
SD of at least four independent experiments.
Note that active Akt (PH domain [residues
4–129]-truncated Akt with a myristoylation
site) promoted cell motility. (c) Akt promotes
cell motility cell autonomously. Cells were
transfected with control vector, active Akt, or
Akt DN, together with pEGFP, for 20 hr. All
the migrated cells were labeled with DiI 2 hr
after transfer to the Boyden chamber. Then,
GFP-negative DiI-labeled cells () as well as
GFP-positive DiI-labeled cells () were
counted. Note that active Akt promoted
motility of GFP-positive cells only. (d) Cells
were transfected with control vector or GSK3
WT, together with active Akt, for 20 hr.
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